| Q41157182 | A patient with progressive dyspnoea |
| Q38259214 | Almanac 2014: cardiovascular imaging |
| Q53033461 | Alterations in regional myocardial deformation assessed by strain imaging in cardiac amyloidosis. |
| Q40891378 | Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg? |
| Q48248526 | Apical left ventricular myocardial dysfunction is an early feature of cardiac involvement in myotonic dystrophy type 1. |
| Q51032903 | Apical sparing pattern of left ventricular myocardial 99mTc-HMDP uptake in patients with transthyretin cardiac amyloidosis. |
| Q34515672 | Assessment of left ventricular twist mechanics by speckle tracking echocardiography reveals association between LV twist and myocardial fibrosis in patients with hypertrophic cardiomyopathy |
| Q92408493 | Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study |
| Q53040683 | Association of ischemic heart disease to global and regional longitudinal strain in asymptomatic aortic stenosis. |
| Q64928002 | Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis. |
| Q38995866 | Basal longitudinal strain predicts future aortic valve replacement in asymptomatic patients with aortic stenosis |
| Q88160287 | Can Nuclear Imaging Techniques Predict Patient Outcome and Guide Medical Management in Hereditary Transthyretin Cardiac Amyloidosis? |
| Q40805808 | Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy? |
| Q92218771 | Cardiac Amyloid - An Update |
| Q39320411 | Cardiac Amyloidosis: Diagnosis and Treatment Strategies |
| Q47128372 | Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis |
| Q36318806 | Cardiac amyloidosis mimicking severe aortic valve stenosis - a case report demonstrating diagnostic pitfalls and role of dobutamine stress echocardiography |
| Q38528406 | Cardiac amyloidosis: where are we today? |
| Q52670660 | Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers. |
| Q42177959 | Cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis |
| Q37629207 | Changes in Left Ventricular Global and Regional Longitudinal Strain During Right Ventricular Pacing |
| Q88008461 | Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction |
| Q48666199 | Clinical applications and prognostic implications of strain and strain rate imaging |
| Q92263303 | Coexistence of aortic valve stenosis and cardiac amyloidosis: echocardiographic and clinical significance |
| Q48628498 | Comparison of the standard and speckle tracking echocardiographic features of wild-type and mutated transthyretin cardiac amyloidoses |
| Q33817028 | Comparison of two-dimensional strain analysis using vendor-independent and vendor-specific software in adult and pediatric patients |
| Q41072464 | Congestive Heart Failure with Preserved Ejection Fraction in a Patient with Light Chain (AL) Amyloidosis and Multiple Myeloma. |
| Q61811866 | Contemporary Imaging Diagnosis of Cardiac Amyloidosis |
| Q91687342 | Deposit Diseases as Differential Diagnosis of Left Ventricular Hypertrophy in Patients with Heart Failure and Preserved Systolic Function |
| Q94564971 | Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist |
| Q98161293 | Diagnosis and treatment of transthyretin-related amyloidosis cardiomyopathy |
| Q59793119 | Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers |
| Q48113077 | Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging |
| Q26776496 | Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis |
| Q89637696 | Diagnostic imaging of cardiac amyloidosis |
| Q58252419 | Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis |
| Q50614147 | Disease-specific differences of left ventricular rotational mechanics between cardiac amyloidosis and hypertrophic cardiomyopathy. |
| Q30360165 | Distribution pattern of left-ventricular myocardial strain analyzed by a cine MRI based deformation registration algorithm in healthy Chinese volunteers. |
| Q89537922 | Early Left Ventricular Systolic Dysfunction Detected by Two-Dimensional Speckle-Tracking Echocardiography in Young Patients with Congenital Generalized Lipodystrophy |
| Q42470986 | Early recognition of apical ballooning syndrome by global longitudinal strain using speckle tracking imaging--the evil eye pattern, a case series |
| Q38322136 | Echocardiography in cardiac amyloidosis. |
| Q91943664 | Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis |
| Q64937697 | Emerging role of echocardiography, cardiac magnetic resonance imaging and 99mTc-labeled bone tracer scintigraphy for the diagnosis of cardiac amyloidosis. |
| Q88185258 | Evaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma Therapy |
| Q64234461 | Functional Changes in Acute Eosinophilic Myocarditis Due to Chemotherapy With Ibrutinib |
| Q34344505 | Hcc-1 is a novel component of the nuclear matrix with growth inhibitory function |
| Q92826292 | Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease |
| Q90678649 | How to Image Cardiac Amyloidosis: A Practical Approach |
| Q41867190 | How to image cardiac amyloidosis |
| Q37054932 | Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish |
| Q41582133 | Impact of monitoring longitudinal systolic strain changes during serial echocardiography on outcome in patients with AL amyloidosis. |
| Q92482901 | Improvement of global longitudinal strain following high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with amyloid light-chain cardiac amyloidosis: a case report |
| Q38547033 | Improving strategies for the diagnosis of cardiac amyloidosis |
| Q38895368 | Incremental Value of Two Dimensional Speckle Tracking Echocardiography in the Functional Assessment and Characterization of Subclinical Left Ventricular Dysfunction. |
| Q89274870 | Left Ventricle Relative Apical Sparing in Cardiac Amyloidosis |
| Q39186807 | Left ventricular hypertrophy or storage disease? the incremental value of speckle tracking strain bull's-eye. |
| Q88393746 | Left ventricular non-compaction and idiopathic dilated cardiomyopathy: the significant diagnostic value of longitudinal strain |
| Q34529537 | Left ventricular strain distribution in healthy dogs and in dogs with tachycardia-induced dilated cardiomyopathy |
| Q89800743 | Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome |
| Q26750739 | Longitudinal strain bull's eye plot patterns in patients with cardiomyopathy and concentric left ventricular hypertrophy |
| Q48611676 | Longitudinal strain of left ventricular basal segments and E/e' ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study. |
| Q92318008 | Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy |
| Q48168782 | Loss of base-to-apex circumferential strain gradient: A specific pattern of Fabry cardiomyopathy? |
| Q50597303 | Mechanical dyssynchrony with phase analysis of gated SPECT: Nap time is over. |
| Q91672194 | Multi-modality imaging in transthyretin amyloid cardiomyopathy |
| Q92793814 | Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies |
| Q89733305 | Multimodality Imaging in Hypertrophic Cardiomyopathy for Risk Stratification |
| Q38782767 | Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document: In collaboration with the 'Working Group on myocardial and pericardial diseases' of the European Society of Cardiology Endorsed by the Indian Academy of Echoc |
| Q91257956 | Myocardial Deformation Pattern Differs between Ischemic and Non-ischemic Dilated Cardiomyopathy: The Diagnostic Value of Longitudinal Strains |
| Q33812497 | Myocardial Deformation in Cardiac Amyloid Light-chain Amyloidosis: Assessed with 3T Cardiovascular Magnetic Resonance Feature Tracking |
| Q90667755 | Myocardial Oxygen Consumption and Efficiency in Patients With Cardiac Amyloidosis |
| Q48593562 | Myocardial strain pattern in patients with cardiac amyloidosis secondary to multiple myeloma: a cardiac MRI feature tracking study |
| Q38838927 | New Cardiac Imaging Algorithms to Diagnose Constrictive Pericarditis Versus Restrictive Cardiomyopathy |
| Q38087315 | New approaches to the clinical diagnosis of inherited heart muscle disease. |
| Q88916922 | Novel Imaging Techniques for Heart Failure |
| Q89035990 | Pattern of myocardial 99mTc-HMDP uptake and impact on myocardial function in patients with transthyretin cardiac amyloidosis |
| Q41272712 | Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics. |
| Q34776977 | Predictive value of assessing diastolic strain rate on survival in cardiac amyloidosis patients with preserved ejection fraction |
| Q47626451 | Predictors of survival stratification in patients with wild-type cardiac amyloidosis. |
| Q102145688 | Prevalence of wild type transtyrethin cardiac amyloidosis in a heart failure clinic |
| Q38444901 | Principles of transthoracic echocardiographic evaluation |
| Q47643557 | Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation |
| Q96304977 | Prognostic assessment of relative apical sparing pattern of longitudinal strain for severe aortic valve stenosis |
| Q40036915 | Prognostic implication of relative regional strain ratio in cardiac amyloidosis. |
| Q92867710 | Rapid progression of aortic and mitral stenosis in a patient with AA amyloidosis: a case report |
| Q38935425 | Recent advances in the noninvasive strategies of cardiac amyloidosis |
| Q47114566 | Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis |
| Q36769403 | Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance. |
| Q33753528 | Regression of cardiac amyloidosis following stem cell transplantation: a comparison between echocardiography and cardiac magnetic resonance imaging in long-term survivors. |
| Q90653131 | Regression of the Anatomic Cardiac Features of Amyloid Light Chain Cardiac Amyloidosis Accompanied by Normalization of Global Longitudinal Strain |
| Q39114674 | Role of Imaging in Evaluating Infiltrative Heart Disease. |
| Q57299899 | Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis |
| Q34392552 | Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques |
| Q38343713 | Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association |
| Q87596316 | Setting the stage for the next step in cardiac amyloidosis imaging: Serial quantitative studies to assess disease activity |
| Q41946701 | Speckle Tracking and Transthyretin Amyloid Cardiomyopathy |
| Q38995468 | Strain Imaging Echocardiography: What Imaging Cardiologists Should Know |
| Q39181170 | Subaortic membrane mimicking hypertrophic cardiomyopathy |
| Q37090794 | Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis |
| Q89925035 | Technetium 99m pyrophosphate radioisotope for diagnosis and prognosis of transthyretin cardiac amyloidosis: A call for collaboration |
| Q89441471 | Technetium pyrophosphate uptake in transthyretin cardiac amyloidosis: Associations with echocardiographic disease severity and outcomes |
| Q60914142 | Ten Years of 2D Longitudinal Strain for Early Myocardial Dysfunction Detection: A Clinical Overview |
| Q37697277 | The Imaging Diagnosis of Less Advanced Cases of Cardiac Amyloidosis: The Relative Apical Sparing Pattern |
| Q41693071 | The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update |
| Q58113525 | The Role of Cardiovascular Magnetic Resonance for Surveillance of Cardiac Performance upon Receipt of Potentially Cardiotoxic Cancer Therapeutics |
| Q92123011 | The Role of Echocardiography in Heart Failure with Preserved Ejection Fraction: What Do We Want from Imaging? |
| Q38074550 | The most important publications of the past year in echocardiography |
| Q97072625 | The role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a Position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council |
| Q38331109 | The role of echocardiography in hypertrophic cardiomyopathy |
| Q48660637 | The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis |
| Q38633389 | The role of imaging in the diagnosis and management of hypertrophic cardiomyopathy |
| Q45065991 | Transthyretin Cardiac Amyloidosis |
| Q36921392 | Transthyretin Cardiac Amyloidosis in Black Americans |
| Q47637174 | Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management Goal |
| Q90653138 | Transthyretin Cardiac Amyloidosis: A Noninvasive Multimodality Approach to Diagnosis Using Transthoracic Echocardiography, 99m-Tc-Labeled Phosphate Bone Scanning, and Cardiac Magnetic Resonance Imaging |
| Q90274848 | Transthyretin cardiac amyloidosis: an update on diagnosis and treatment |
| Q50093215 | Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement |
| Q40488912 | Upregulation of rat P23 (a member of the YjgF protein family) by fasting, glucose diet and fatty acid feeding. |
| Q38834998 | Use of Noninvasive Imaging in Cardiac Amyloidosis |
| Q58804421 | Value of cardiac biomarker measurement in the differential diagnosis of infiltrative cardiomyopathy patients with preserved left ventricular systolic function |
| Q95729110 | Value of natriuretic peptides and tissue Doppler imaging in the estimation of left ventricular filling pressure in patients with cardiac amyloidosis |
| Q34487487 | Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction |
| Q55425790 | Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies. |
| Q86830923 | [Echocardiographic evaluation of systolic left ventricular function in heart failure: value of alternative parameters for determination of ejection fraction] |
| Q52866825 | [Hypertrophic and restrictive cardiomyopathy. Differentiation by imaging]. |